Apyx Medical Inc expected to post a loss of 8 cents a share - Earnings Preview

Apyx Medical

04/08/2026 21:56

Apyx Medical Inc APYX.OQ APYX.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Clearwater Florida-based  company is expected to report a 15.8% increase in revenue to $13.175 million from $11.37 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Apyx Medical Inc is for a loss of 8 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Apyx Medical Inc is $6.00, about 43.5% above its last closing price of $4.18
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.11
-0.11
-0.05
Beat
52.8
Dec. 31 2026
-0.06
-0.06
-0.03
Beat
47.6
Sep. 30 2025
-0.10
-0.10
-0.05
Beat
51.2​
Jun. 30 2025
-0.09
-0.09
-0.09
Met
3.6
​​Mar. 31 2025
-0.12
-0.12
-0.10
Beat
16.7
Dec. 31 2024
-0.17
-0.16
-0.12
Beat
25​
Sep. 30 2024
-0.19
-0.19
-0.14
Beat
24.6
Jun. 30 2024
-0.20
-0.20
-0.19
Beat
4.1
This summary was machine generated August 4 at 20:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)